View graph of relations

    Research Statement

    Dimitrios A. Lamprou (Ph.D., MBA) is Reader in Pharmaceutical Engineering (May 2018 – Present) and MSc Programme Director at School of Pharmacy in Queen's University Belfast (UK), and Visiting Researcher (Sep 2016 – Present) at University of Strathclyde (Glasgow, UK). Prior to his current appointment(s), Dimitrios was Senior Lecturer in Pharmaceutics & Drug Delivery (Sep 2016 – Apr 2018) at University of Kent (UK), Lecturer B in Pharmaceutical Sciences (Aug 2012 Aug 2016) and Postdoctoral Fellow in Biomaterials and Drug Delivery Systems (Oct 2009 Jul 2012) at Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS) at University of Strathclyde (UK). Dimitrios was also Visiting Scientist at Massachusetts Institute of Technology (MIT Center for Biomedical Engineering; US) in 2010 and at Aristotle University of Thessaloniki (Department of Pharmaceutical Technology; Greece) in 2011. Dimitrios has experience of teaching (including MPharm & MSc accreditations, and preparing 2 de novo Master's degree programmes) in Higher Education (Pharmacy Departments in UK) since Oct 2006, conducting research and securing National (e.g. EPSRC, SULSA) and International (e.g. HORIZON 2020, Commonwealth) Funding (Over £2M) as Co-I or PI, and is currently involved in a variety of industry projects and collaborates with academic partners and clinicians within the UK and internationally. He is Committee Member (Secretary: Sep 2017 – Present) at the United Kingdom and Ireland Controlled Release Society (UKICRS) since Oct 2013, external Ph.D. viva examiner (15+) for UK and International Institutions (e.g. in India and Italy), and referees for journals (30+ Pharmaceutical and related; Impact Factor: 3 to 14), publishers (e.g. Elsevier) and for 10+ research funding bodies internationally (e.g. Hungary) and nationally (e.g. EPSRC, MRC). Dimitrios, since 2008 has authored over 60 articles in high impact multidisciplinary journals, over 200 conference abstracts (poster and podium presentations), over 70 Oral/Invited presentations, and has experience of supervising as PI or Co-I Post-Doc's, over 100 Undergraduate and Postgraduate Project students (e.g. Erasmus, MChem, MPharm, MPhil, MRes, MSc) and over 15 Ph.D. students to successful completion (< 4 years), all of whom are now further developing their careers in either Academic or Industrial positions. Dimitrios research and academic leadership has been recognised in a range of awards including the Royal Pharmaceutical Society (RPS) Science Award (2017) and the Scottish Universities Life Sciences Alliance (SULSA) Leaders Scheme Award (2013).

    Achievements and Distinctions

    Academic / Professional Qualifications: Dimitrios was trained in multi-disciplinary areas and in first class laboratories (e.g. in Greece, UK, USA). He received Bachelor's BEng (Hons) degree in Medical Engineering from the University of Bradford (UK), Master's in Biomedical Engineering from the University of Surrey (UK), working on Tissue Engineered Vascular Grafts, and Ph.D. in Bio-Surface Chemistry (Ph.D. Thesis Viva took place in Nov 2009) in a collaborative project between the University of Portsmouth (UK) and the Defence Science and Technology Laboratory (Dstl) - Porton Down (UK), by working in areas such as biomaterials, bioadhesion and drug delivery. Also holds Certificate in Computing (with experience in chemometrics using PCA/PLS and other multivariate approaches), PgCert in Scientific Research Methods for Laboratory Scientists from the University of Portsmouth (UK), PgDip in Advanced Academic Studies from the University of Strathclyde (UK) and Master of Business Administration (MBA) from Middlesex University (UK). Dimitrios has also participated in numerous workshops, seminars and courses about management, leadership, marketing, teaching, and has gain advance experience in a range of research techniques.

    Research Interests

    · Our research group focus is towards the successful delivery of therapeutic agents in a controlled and targeted manner and the development of advanced delivery systems for a variety of applications.

    · Our ambition is to pursue the most exciting, challenging, up-to-date and hot topics in the area of Pharmaceutical Science & Technology.

    · We are applying aspects of Pharmaceutical Technology to a range of areas such as cancer, antimicrobial resistance and nanomedicine development.

    · Our current research involves both the study of material characteristics as well as the application of such knowledge to the design and manufacture of pharmaceutical products including the implementation of concepts such as Quality by Design (QbD) & Process Analytical Technology (PAT), and the use of state-of-the-art Nanocharacterisation Techniques (e.g. AFM, μCT, ToF-SIMS).

    The current group research interests are focused on five distinct areas:

    1. Biosurface Engineering: Development of modified surfaces for various biomedical and pharmaceutical applications (e.g. antifouling, nanobio-interactions, protein-excipient interactions, templating). Including, the development of modified micro-electro-mechanical Systems (MEMS) devices for various applications in the biomedical field (e.g. biosensors).

    2. Electrospinning: Electrospun polymeric nanofibers production for a variety of drug delivery and tissue engineering applications (e.g. hernia repair, mesh implants, wound healing).

    3. Microfluidics: Engineering of novel drug delivery systems (e.g. lipid - Liposomes & SLNs, polymeric - PLGA) using microfluidics and comparison with traditional formulation methods (e.g. extrusion, thin-film hydration method) for imaging (e.g. MRI) and treatment / targeting using new or currently available anticancer, antidiabetic and anti-infective drugs. Including, in-house fabrication of microfluidic chips by 3D printing and soft photolithography. Studies include: Formulation, physicochemical characterization, in vitro & in vivo evaluation.

    4. Pharmaceutical 3D Printing: Manufacturing of drug delivery systems & medical devices (e.g. catheters, mesh implants, microneedles, stents, and tablets) using innovative 3D printing technologies. Including in-house prepared filaments by hot-melt extrusion (HME) and granules/pellets by Twin Screw Granulation (TSG).

    5. Pharmaceutical Management: Project Management & Risk Management in Pharmaceutical Industry, Quality by Design (QbD).


    • Teaching on the Pharmacy MPharm Degree.


    · Research Excellence Framework (REF) Reading Group Member.

    · Athena SWAN Self-Assessment Team (SAT) Member.

    · Assist the School in Career Events and Open Days.

    Willingness to take PhD students


    PhD projects

    Interested in joining our team? We are always looking for enthusiastic, self-motivated, talented, and technically skilled people who may be interested to work or study in our laboratory and we are keen to look into the possibilities of hosting fellowships and visitors in any of our Group Research Interests.

    View all

    Frequent Journals

    View all »

    • Pharmaceutics (Journal)

      Activity: Publication peer-review and editorial work typesEditorial activity

    • Polymers (Journal)

      Activity: Publication peer-review and editorial work typesEditorial activity

    • Men’s Health Seminar

      Activity: Participating in or organising an event typesParticipation in workshop, seminar, course

    View all

    Contribution to conference papers, events and activities

    ID: 149686500